Allergic Contact Dermatitis
📧 Sign up to get email alerts when something new happens for Allergic Contact Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update assessing a contact dermatitis model to study skin inflammation using biologic medications.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: The Effects of Dupilumab on Allergic Contact Dermatitis [Phase 4]
Phase 4 trial evaluating dupilumab for allergic contact dermatitis with results posted in 2026. The study is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases [NA]
This ClinicalTrials.gov update describes an ongoing study examining how environmental exposure to heavy metals, nanoparticles, and other con…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/3 study using a contact dermatitis model with biologic medications to study skin inflammation…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Rate of Allergic Contact Dermatitis and Cosmetic Outcomes [NA]
An ongoing clinical trial update from West Virginia University examining the rate of allergic contact dermatitis and cosmetic outcomes in pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Aquacel Hypersensitivity Dressing in TJAs [Phase 4]
Phase 4 clinical trial evaluating Aquacel Hypersensitivity Dressing in total joint arthroplasty has completed, focusing on allergic skin rea…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis [Phase 3]
A Phase 3 trial evaluating interleukin-1 beta targeted therapy for allergic contact dermatitis has completed, with results posted.
-
FDA approval · 2025-02-26FDA Approved: FLUOCINONIDE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved fluocinonide from Quagen Pharmaceuticals LLC under an Original Application (ANDA 216389). This is a generic topical corticoster…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Investigation of Nickel Sensitization After Percutaneous Implantation of Patent Foramen Ovale Occluder [NA]
A completed clinical trial update evaluating whether nickel sensitization occurs after percutaneous implantation of a patent foramen ovale o…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Contact Allergy to Rubber Accelerators - a Clinical Study [NA]
A completed clinical trial from Denmark evaluating allergic contact dermatitis related to rubber accelerators.
-
FDA approval · 2024-12-09FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approval of Hikma's generic Triamcinolone Acetonide (ANDA 215254) as an original-application topical corticosteroid product for dermatol…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Diagnostic Accuracy of Teledermatology in Patch Test Interpretation [NA]
This update reports the results of a completed study evaluating how accurately teledermatology can interpret patch test results in diagnosin…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis [Phase 2]
Phase 2 trial evaluating EB01 Cream for chronic allergic contact dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: SPT for Sensitization of Collagen Dressing [NA]
Completed clinical trial (NCT06271993) assessing sensitization to a collagen dressing for allergic skin reactions; results were posted on 20…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation. [NA]
This clinical trial update reports completion of standardisation work for Juniperus oxycedrus and Cupressus arizonica allergen extracts by I…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Patient Experience and Quality of Patch Testing on the Legs vs Back [NA]
Clinical trial update comparing patient experience and the quality of patch testing performed on the legs versus the back for allergic conta…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Clinical Observations of Pain and Pruritus Induced by Exposure to Allergic Contact Dermatitis Caused by Macrolides
A clinical trial is examining pain and pruritus associated with allergic contact dermatitis triggered by exposure to macrolide antibiotics.
-
FDA approval · 2023-12-28FDA Approved: CLOBETASOL PROPIONATE ANDA — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved the original ANDA for clobetasol propionate topical from Macleods Pharmaceuticals Limited, enabling a generic version of th…
-
FDA approval · 2023-11-29FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for clobetasol propionate, a potent topical corticosteroid, enabling an approved supplement…
-
FDA approval · 2021-02-05FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approves a generic Triamcinolone Acetonide topical product under an Original Application (ANDA) for Padagis Israel Pharmaceuticals Ltd.
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents [NA]
A completed clinical trial evaluating T.R.U.E. Test allergens in children and adolescents for allergic contact dermatitis; results posted in…
-
FDA approval · 2020-07-14FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Viona Pharmaceuticals Inc)
FDA approved the original application for Betamethasone Dipropionate by Viona Pharmaceuticals Inc, granting it as a generic topical corticos…
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Bioequivalence of Ethylenediamine Dihydrochloride Study [Phase 4]
A Phase 4 trial update reports bioequivalence testing for Ethylenediamine Dihydrochloride in Allergic Contact Dermatitis; results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Red Grape Polyphenol Oral Administration to Women Affected by Nickel-mediated Allergic Contact Dermatitis [NA]
A completed clinical trial evaluating red grape polyphenol oral administration for nickel-mediated allergic contact dermatitis with results …
-
FDA approval · 2019-12-18FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved an original application for Betamethasone dipropionate by Lupin Pharmaceuticals, Inc., granting a generic topical corticosteroi…